298 related articles for article (PubMed ID: 26149053)
21. Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and Tricuspid Valves: The Largest Survival Analysis to Date.
Taherkhani M; Hashemi SR; Hekmat M; Safi M; Taherkhani A; Movahed MR
Tex Heart Inst J; 2015 Dec; 42(6):543-7. PubMed ID: 26664307
[TBL] [Abstract][Full Text] [Related]
22. Strategies for Improving Endothelial Cell Adhesion to Blood-Contacting Medical Devices.
Wolfe JT; Shradhanjali A; Tefft BJ
Tissue Eng Part B Rev; 2022 Oct; 28(5):1067-1092. PubMed ID: 34693761
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
[TBL] [Abstract][Full Text] [Related]
24. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
[TBL] [Abstract][Full Text] [Related]
25. Unravelling Surface Modification Strategies for Preventing Medical Device-Induced Thrombosis.
Luu CH; Nguyen NT; Ta HT
Adv Healthc Mater; 2024 Jan; 13(1):e2301039. PubMed ID: 37725037
[TBL] [Abstract][Full Text] [Related]
26. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design.
Scharn DM; Daamen WF; van Kuppevelt TH; van der Vliet JA
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):66-72. PubMed ID: 22001149
[TBL] [Abstract][Full Text] [Related]
27. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.
Brumberg RS; Back MR; Armstrong PA; Cuthbertson D; Shames ML; Johnson BL; Bandyk DF
J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227
[TBL] [Abstract][Full Text] [Related]
28. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
Jennings DL; Weeks PA
Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
[TBL] [Abstract][Full Text] [Related]
29. Valvar heart disease and prosthetic heart valves.
Goldsmith I; Turpie AG; Lip GY
BMJ; 2002 Nov; 325(7374):1228-31. PubMed ID: 12446543
[No Abstract] [Full Text] [Related]
30. Heparin-bonded expanded polytetrafluorethylene grafts in hemodialysis access.
Olsha O; Goldin I; Shemesh D
J Vasc Access; 2016 Mar; 17 Suppl 1():S79-84. PubMed ID: 26951912
[TBL] [Abstract][Full Text] [Related]
31. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?
Conn G; Kidane AG; Punshon G; Kannan RY; Hamilton G; Seifalian AM
Expert Rev Med Devices; 2006 Mar; 3(2):245-61. PubMed ID: 16515390
[TBL] [Abstract][Full Text] [Related]
32. Maintaining vascular access: the management of hemodialysis arteriovenous grafts.
Schild AF
J Vasc Access; 2010; 11(2):92-9. PubMed ID: 20155717
[TBL] [Abstract][Full Text] [Related]
33. On the influence of flow conditions and wettability on blood material interactions.
Spijker HT; Graaff R; Boonstra PW; Busscher HJ; van Oeveren W
Biomaterials; 2003 Nov; 24(26):4717-27. PubMed ID: 14530069
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic occlusion of an aortic-root xenograft during left ventricular assistance.
Demirozu ZT; Ho J; Bogaev RC; Lemaire SA; Coselli JS; Frazier OH
Tex Heart Inst J; 2011; 38(1):66-7. PubMed ID: 21423473
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
Schlitt A; Hamilton K; Maegdefessel L; Dahm M; Theis C; Eichler M; Brockmann O; Steinseifer U; Hauroeder B; Hitzler WE; Rupprecht HJ
J Heart Valve Dis; 2006 Nov; 15(6):809-14. PubMed ID: 17152789
[TBL] [Abstract][Full Text] [Related]
36. [New study results in cardiology].
Stiefelhagen P
Internist (Berl); 2006 Nov; 47(11):1186, 1188-90. PubMed ID: 17033779
[No Abstract] [Full Text] [Related]
37. Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?
Massicotte MP; Bauman ME; Murray J; Almond CS
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S343-50. PubMed ID: 26149046
[TBL] [Abstract][Full Text] [Related]
38. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
[TBL] [Abstract][Full Text] [Related]
39. A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery.
Desai PH; Kurian D; Thirumavalavan N; Desai SP; Ziu P; Grant M; White C; Landis RC; Poston RS
Anesth Analg; 2009 Nov; 109(5):1387-94. PubMed ID: 19843776
[TBL] [Abstract][Full Text] [Related]
40. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
